Validations: PPQ/CPV Tailoring for ATMP
Templates: ATMP PPQ Protocols and CPV Plans Templates: ATMP PPQ Protocols and CPV Plans Understanding the Importance of PPQ in ATMP Development Process Performance Qualification (PPQ) is a critical phase in the lifecycle of Advanced Therapy Medicinal Products (ATMPs). It serves as a foundation for ensuring that manufacturing processes consistently produce products that meet predetermined criteria for quality, safety, and…
Templates: ATMP PPQ Protocols and CPV Plans Templates: ATMP PPQ Protocols and CPV Plans 1. Introduction to PPQ and CPV in ATMP Validation Process Performance Qualification (PPQ) and Continued Process Verification (CPV) are critical components in the validation landscape of Advanced Therapy Medicinal Products (ATMPs). As regulatory bodies globally, including the FDA, EMA, and MHRA, set stringent expectations on the…
Supplier/Raw Material Variability in ATMP Supplier/Raw Material Variability in ATMP Understanding Advanced Therapy Medicinal Products (ATMP) Advanced Therapy Medicinal Products (ATMPs) represent a complex category of innovative medicines that include gene therapy, somatic cell therapy, and tissue-engineered products. The growing interest in ATMPs comes from their potential to provide effective treatments for conditions previously deemed untreatable, such as genetic disorders…
Batch Definition in ATMP: What Counts In the ever-evolving landscape of Advanced Therapy Medicinal Products (ATMP), meticulous validation processes become foundational to ensuring safety, efficacy, and regulatory compliance. This comprehensive tutorial guide sets out to explore the intricacies of batch definition in ATMP, particularly addressing the elements involved in process performance qualification (PPQ), viral clearance validation, and the importance of…
Equivalence Testing with Sparse Data Equivalence Testing with Sparse Data in Biologics and ATMP Validation Introduction to PPQ and Viral Clearance Validation Process Performance Qualification (PPQ) is a crucial phase in the validation of biologics and advanced therapy medicinal products (ATMP). This phase ensures that the manufacturing process consistently produces a product that meets its predetermined specifications and quality attributes….
Patient Risk Lens in PPQ/CPV Decisions Patient Risk Lens in PPQ/CPV Decisions The successful validation of products within the biologics and advanced therapy medicinal products (ATMP) sectors is reliant upon a robust understanding of various processes and regulations. As professionals in the pharmaceutical field, it is imperative to utilize a comprehensive approach that aligns patient safety with regulatory expectations. This…
Regulatory Language for ATMP PPQ/CPV Regulatory Language for ATMP PPQ/CPV Advanced Therapy Medicinal Products (ATMPs) are increasingly relevant in modern therapeutic strategies, necessitating rigorous validation protocols tailored to ensure safety and efficacy. This guide serves as a comprehensive resource for professionals in pharmaceuticals and biotechnology, specifically focusing on the Process Performance Qualification (PPQ) and Continued Process Verification (CPV) aspects for…
Short-Run SPC for ATMP: What Works In the rapidly evolving landscape of Advanced Therapy Medicinal Products (ATMPs), the imperative for optimal viral clearance validation, particularly in the context of short-run processes and Quality Assurance strategies, cannot be overstated. This comprehensive guide aims to elucidate effective practices for establishing robust short-run Process Performance Qualification (PPQ) frameworks and Critical Process Variable (CPV)…
Model/PAT Monitoring in ATMP: Health Checks Model/PAT Monitoring in ATMP: Health Checks Introduction to ATMP Validation Principles Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biopharmaceuticals, encompassing gene therapy, somatic cell therapy, and tissue-engineered products. Validation in ATMP manufacturing is crucial to ensure compliance with regulatory standards set forth by organizations such as the FDA in the…
Stability & Hold-Time in ATMP: What’s Defensible Stability & Hold-Time in ATMP: What’s Defensible Advanced Therapy Medicinal Products (ATMPs) represent a significant advancement in therapeutics, providing treatments for conditions that were previously challenging or impossible to manage. The validation of these products, particularly in the context of stability and hold-time, is crucial. In this guide, we’ll explore the methodologies and…